The Group B Streptococcal β and Pneumococcal Hic Proteins Are Structurally Related Immune Evasion Molecules That Bind the Complement Inhibitor Factor H in an Analogous Fashion 1

Complement evasion by different mechanisms is important for microbial virulence and survival in the host. One strategy used by pathogenic bacteria is to bind the soluble complement inhibitor factor H (fH) to their surfaces. In group B streptococci and pneumococci, fH binding has been shown to be mediated by the surface proteins β and Hic, respectively. We showed previously that Hic binds to the middle region of fH and protects the pneumococcus from opsonophagocytosis. As the β protein and Hic are structurally closely related, we wanted to compare the fH binding characteristics of these two proteins. By using direct binding assays with radiolabeled proteins and surface plasmon resonance analysis we show that both β and Hic bind to the short consensus repeats 8–11 and 12–14 in the middle region of fH. Peptide mapping analysis suggested that the fH-binding sites on β and Hic were composed of discontinuous and partially homologous sequences. Thus, the bacterial virulence proteins use multiple binding sites on fH to secure high avidity. Also, the functionally active sites on fH are thereby left free to inhibit C3b deposition and opsonophagocytosis. These results reveal the evolutionary conservation of an analogous immune evasion strategy in different types of pathogenic streptococci. Importantly, the respective virulence factors could be exploited in the development of protein-based vaccines against these pathogens.

[1]  L. Bevanger Ibc proteins as serotype markers of group B streptococci. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

[2]  S. Meri,et al.  Complement resistance mechanisms of streptococci. , 2003, Molecular immunology.

[3]  G. Lindahl,et al.  A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface , 2002, Journal of bacteriology.

[4]  K. Boyer,et al.  Group B streptococcal infections. , 2002, Pediatrics in review.

[5]  U. H. Stroeher,et al.  The Human Complement Regulator Factor H Binds Pneumococcal Surface Protein PspC via Short Consensus Repeats 13 to 15 , 2002, Infection and Immunity.

[6]  G. Lindahl,et al.  Streptococcal β Protein Has Separate Binding Sites for Human Factor H and IgA-Fc* , 2002, The Journal of Biological Chemistry.

[7]  L. Björck,et al.  Streptococcus pneumoniae Evades Complement Attack and Opsonophagocytosis by Expressing the pspC Locus-Encoded Hic Protein That Binds to Short Consensus Repeats 8–11 of Factor H1 , 2002, The Journal of Immunology.

[8]  L. McDaniel,et al.  PspC, a Pneumococcal Surface Protein, Binds Human Factor H , 2001, Infection and Immunity.

[9]  L. Björck,et al.  Hic, a Novel Surface Protein of Streptococcus pneumoniae That Interferes with Complement Function* , 2000, The Journal of Biological Chemistry.

[10]  S. Meri,et al.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b. , 2000, The Journal of biological chemistry.

[11]  D. Pérez-Caballero,et al.  Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high‐affinity group A Streptococcus binding site in FHL‐1 , 2000, European journal of immunology.

[12]  G. Lindahl,et al.  Group B Streptococcal Surface Proteins as Targets for Protective Antibodies: Identification of Two Novel Proteins in Strains of Serotype V , 1999, Infection and Immunity.

[13]  S. Meri,et al.  Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. , 1999, Journal of immunology.

[14]  S. Meri,et al.  Complement-resistance mechanisms of bacteria. , 1999, Microbes and infection.

[15]  A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[16]  P. Zipfel,et al.  Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.

[17]  V. Fischetti,et al.  M Protein of the Group A StreptococcusBinds to the Seventh Short Consensus Repeat of Human Complement Factor H , 1998, Infection and Immunity.

[18]  P. Zipfel,et al.  The C-terminus of factor H: monoclonal antibodies inhibit heparin binding and identify epitopes common to factor H and factor H-related proteins. , 1998, The Biochemical journal.

[19]  P. Coll,et al.  Group B streptococcal meningitis in adults: report of twelve cases and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Hammerschmidt,et al.  SpsA, a novel pneumococcal surface protein with specific binding to secretory Immunoglobulin A and secretory component , 1997, Molecular microbiology.

[21]  D. Lublin,et al.  Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.

[22]  P. Zipfel,et al.  Mapping of the domains required for decay acceleration activity of the human factor H‐like protein 1 and factor H , 1996, European journal of immunology.

[23]  M. Pangburn,et al.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Lindahl,et al.  Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha , 1996, Infection and immunity.

[25]  P. Zipfel,et al.  Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. , 1995, Journal of immunology.

[26]  P. Zipfel,et al.  The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. , 1995, Gene.

[27]  D. Lublin,et al.  Identification of complement regulatory domains in human factor H. , 1995, Journal of immunology.

[28]  G. Lindahl,et al.  Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.

[29]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[30]  S. Meri,et al.  Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. , 1994, Biochemical and biophysical research communications.

[31]  A. Schuchat,et al.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.

[32]  G. Lindahl,et al.  Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections , 1993, The Journal of experimental medicine.

[33]  S. Meri,et al.  Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.

[34]  G. Lindahl,et al.  Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline‐rich region with unique structure and isolation of N‐terminal fragments with IgA‐binding capacity , 1991, European journal of immunology.

[35]  G. Lindahl,et al.  Characterization of an IgA receptor from group B streptococci: specificity for serum IgA , 1990, European journal of immunology.

[36]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[37]  Eugene W. Myers,et al.  Basic local alignment search tool. Journal of Molecular Biology , 1990 .

[38]  V. Fischetti,et al.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  E. Gotschlich,et al.  A surface receptor specific for human IgA on group B streptococci possessing the Ibc protein antigen , 1984, The Journal of experimental medicine.

[40]  Dwight R. Johnson,et al.  Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes , 1984, Journal of clinical microbiology.

[41]  J. Sykes,et al.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3α, 6α-diphenyl glycoluril (Iodogen) , 1981 .

[42]  S. Barbero,et al.  [Infectious diseases in the fetus and newborn infant]. , 1977, Archivio per le scienze mediche.

[43]  C. P. Kenny,et al.  Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance Spectroscopy , 1977 .

[44]  D. Kasper,et al.  Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus , 1976, The Journal of experimental medicine.

[45]  D. Kasper,et al.  Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis. , 1973, Journal of immunology.

[46]  K. Nicholas,et al.  GeneDoc: Analysis and visualization of genetic variation , 1997 .

[47]  J. Sykes,et al.  Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenyl glycoluril (Iodogen). , 1981, Analytical biochemistry.